For a research-based pharmaceutical company to be successful in the 1990s. it must have a strategic plan for the global development of new chemical entities. Global development can be defined as an attempt to reach all major markets as rapidly as possible and for many companies these will include the United States. Japan. Germany. France. Italy. UK and Canada. which together represent approximately 85% of the pharmaceutical market in the developed world. The mutual acceptance of foreign clinical data would reduce the time and resources required to develop a new medicine for the international market by eliminating the requirement for the routine repetition of clinical studies in local populations. In Japan this has been largely based on the belief that genetic differences in respon siveness may result in a different benefit/risk assessment for a new mediCine. while requests in Europe and the United States for local data relate mainly to methodological and cultural considerations. The importance of this issue has been recognised internationally as it was one of the topics discussed at the International Conference on Harmonisation in Orlando (October 1993) and it is currently on the programme for ICH3 which will be convened in Yokohama in Japan in November 1995.
"synopsis" may belong to another edition of this title.
Shipping:
US$ 20.02
From United Kingdom to U.S.A.
Shipping:
FREE
Within U.S.A.
Seller: booksXpress, Bayonne, NJ, U.S.A.
Soft Cover. Condition: new. Seller Inventory # 9789401046213
Quantity: 10 available
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New. Seller Inventory # 20348245-n
Quantity: 5 available
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Condition: New. Seller Inventory # ABLIING23Apr0412070054739
Quantity: Over 20 available
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Condition: NEW. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Seller Inventory # ria9789401046213_lsuk
Quantity: Over 20 available
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -For a research-based pharmaceutical company to be successful in the 1990s. it must have a strategic plan for the global development of new chemical entities. Global development can be defined as an attempt to reach all major markets as rapidly as possible and for many companies these will include the United States. Japan. Germany. France. Italy. UK and Canada. which together represent approximately 85% of the pharmaceutical market in the developed world. The mutual acceptance of foreign clinical data would reduce the time and resources required to develop a new medicine for the international market by eliminating the requirement for the routine repetition of clinical studies in local populations. In Japan this has been largely based on the belief that genetic differences in respon siveness may result in a different benefit/risk assessment for a new mediCine. while requests in Europe and the United States for local data relate mainly to methodological and cultural considerations. The importance of this issue has been recognised internationally as it was one of the topics discussed at the International Conference on Harmonisation in Orlando (October 1993) and it is currently on the programme for ICH3 which will be convened in Yokohama in Japan in November 1995. 284 pp. Englisch. Seller Inventory # 9789401046213
Quantity: 2 available
Seller: GreatBookPricesUK, Castle Donington, DERBY, United Kingdom
Condition: NEW. Seller Inventory # 20348245-n
Quantity: 5 available
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
Condition: NEW. Editor(s): Walker, S.R.; Lumley, Cyndy E.; McAuslane, Neil. Series: Centre for Medicines Research Workshop. Num Pages: 262 pages, biography. BIC Classification: MBN; MMG. Category: (P) Professional & Vocational. Dimension: 240 x 160 x 15. Weight in Grams: 457. . 2012. Softcover reprint of the original 1st ed. 1994. Paperback. . . . . Seller Inventory # V9789401046213
Quantity: 15 available
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - For a research-based pharmaceutical company to be successful in the 1990s. it must have a strategic plan for the global development of new chemical entities. Global development can be defined as an attempt to reach all major markets as rapidly as possible and for many companies these will include the United States. Japan. Germany. France. Italy. UK and Canada. which together represent approximately 85% of the pharmaceutical market in the developed world. The mutual acceptance of foreign clinical data would reduce the time and resources required to develop a new medicine for the international market by eliminating the requirement for the routine repetition of clinical studies in local populations. In Japan this has been largely based on the belief that genetic differences in respon siveness may result in a different benefit/risk assessment for a new mediCine. while requests in Europe and the United States for local data relate mainly to methodological and cultural considerations. The importance of this issue has been recognised internationally as it was one of the topics discussed at the International Conference on Harmonisation in Orlando (October 1993) and it is currently on the programme for ICH3 which will be convened in Yokohama in Japan in November 1995. Seller Inventory # 9789401046213
Quantity: 1 available
Seller: Kennys Bookstore, Olney, MD, U.S.A.
Condition: NEW. Editor(s): Walker, S.R.; Lumley, Cyndy E.; McAuslane, Neil. Series: Centre for Medicines Research Workshop. Num Pages: 262 pages, biography. BIC Classification: MBN; MMG. Category: (P) Professional & Vocational. Dimension: 240 x 160 x 15. Weight in Grams: 457. . 2012. Softcover reprint of the original 1st ed. 1994. Paperback. . . . . Books ship from the US and Ireland. Seller Inventory # V9789401046213
Quantity: 15 available
Seller: moluna, Greven, Germany
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. For a research-based pharmaceutical company to be successful in the 1990s. it must have a strategic plan for the global development of new chemical entities. Global development can be defined as an attempt to reach all major markets as rapidly as possible a. Seller Inventory # 5831404
Quantity: Over 20 available